Five abstracts from Crinetics Pharmaceuticals’s clinical development programs, including four late-breaking abstracts, will be presented at the Endocrine Society’s annual meeting, ENDO 2024, taking place June 1-4, 2024 in Boston – including initial data from a Phase 2 Trial of atumelnant in congenital adrenal hyperplasia (CAH). “This year’s Endocrine Society meeting represents a major milestone for...
Neurocrine Biosciences, Inc. and Diurnal Ltd., a Neurocrine Biosciences company, in May presented baseline data from the CAHtalyst™ Phase 3 studies of crinecerfont in adult and pediatric patients with congenital adrenal hyperplasia (CAH), and modified-release hydrocortisone (Chronocort®) data for a Phase 2 clinical study (CHAMPAIN) in participants with primary adrenal insufficiency and in a Phase 3 extension study in...
In honor of National Asian American and Pacific Islander Heritage Month, Endocrine News reached out to several of our U.S.-based Asian members to get their thoughts on their careers, accomplishments, goals, and even their challenges, as well as advice they have for any young Asian American endocrinologists just beginning their careers. Since 2009, when President...Winners Announced for the Endocrine Society’s 2024 Endocrine Images Art Competition
The Endocrine Society is delighted to announce that Lily Ng, PhD, and Douglas Forrest, PhD, have won the Society’s 2024 Endocrine Images Art Competition for their image of the astrocyte cell that expresses type 2 deiodinase. Now in its third year, the Art Competition celebrates the beauty of endocrine science as seen through the lens...
Good Vibrations: A New FDA-Approved Device Could Offer a Solution for Osteopenia Treatment
In a first for the treatment of osteopenia, the Osteoboost — a wearable device that delivers precise vibrations to the spine and hips — promises to offer a new form of therapy for clinicians treating postmenopausal women dealing with a loss of bone density. At the beginning of 2024, the U.S. Food and Drug...
The Joy of Endocrinology: Joy Y. Wu, MD, PhD, Breaks the Glass and Bamboo Ceilings
As Endocrine News celebrates Asian American and Pacific Islander Heritage Month, we talk to Joy Y. Wu, MD, PhD, chief of the Division of Endocrinology at Stanford University about her personal and professional journey through the field of endocrinology as well as how her career path has been shaped by her mentors, colleagues, and especially...Endocrine Society, ESE Publish Joint Guideline on Glucocorticoid-Induced Adrenal Insufficiency
To kick off a new guideline-writing partnership between the Endocrine Society and the European Society of Endocrinology (ESE), a new guideline on glucocorticoid-induced adrenal insufficiency has just been released. The joint guideline, which was published in the Societies’ respective journals, is designed to help clinicians manage patients who have, or are at risk of developing,...
Endocrine Society past-president Henry M. Kronenberg, MD, has been elected to the National Academy of Sciences (NAS), which recognizes achievement in science and provides science, engineering, and health policy advice to the federal government and other organizations. Kronenberg, who served as Endocrine Society president from 2016 to 2017, has been chief of the Endocrine Unit...
